Health Condition 1: null- BawÄ?sÄ«r DÄ?miya (Bleeding Piles) Health Condition 2: K648- Other hemorrhoids
Conditions
Interventions
Intervention1: Habb-e-Bawaseer Damiya ( 259 mg): 1 tablet orally once daily with water one hour after meals for two weeks
Control Intervention1: nil: nil
Sponsors
Central Council for Research in Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of any sex in the age group 19 to 65 years 2. Patients with a diagnosis of First and Second Degree Hemorrhoids presenting with any of the following symptoms: 3.Bleeding Per Rectum (JarayÄ?n al-Dam fiâ??l Maqâ??ad): bright-red, painless bleeding 4. Mucoid Anal/ Perianal Discharge (SayalÄ?n al-Maqâ??ad MukhÄ?tÄ«): mucus discharge 5. Pruritus Ani (Hikka al-Maqâ??ad) 6. Mucosal Prolapse (KhurÅ«j al-MukhÄ?tÄ«yya) with Spontaneous Reduction 7. Rectal/ Anal Pain (Wajaâ?? al-Maqâ??ad): on prolapse
Exclusion criteria
Exclusion criteria: 1. Third & Fourth Degree Haemorrhoids, anal fissure, anal fistula, IBD, Diabetes Mellitus 2. Known cases of other clinically significant co-morbid conditions (severe hepatic, renal, cardiovascular disorders, etc.) that in the opinion of the investigator could affect the efficacy and safety outcome of the study 3. Patients with laboratory values outside the normal limits or those with values considered abnormal in the opinion of the investigator 4. Known hypersensitivity to study drug or any of its ingredients 5. History of alcohol and drug abuse 6. Pregnant and Lactating Women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in signs and symptoms of BawÄ?sÄ«r DÄ?miya (Bleeding Piles)Timepoint: 2 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: At baseline and after two weeks | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed